TrialBMC neurology2022

Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.

Jessica Ailani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.